Status:
RECRUITING
The Role of Oxytocin in the Second Stage of Labor
Lead Sponsor:
Washington University School of Medicine
Collaborating Sponsors:
University of Michigan
Conditions:
Labor Complication
Eligibility:
FEMALE
Phase:
NA
Brief Summary
This is a randomized controlled trial investigating the utility of oxytocin administration in the second stage of labor.
Detailed Description
Oxytocin is widely used on Labor and Delivery units throughout the world.Laboring patients are most likely to initiate oxytocin in the first stage of labor. Among those who receive oxytocin, first sta...
Eligibility Criteria
Inclusion
- Nulliparous pregnant women \>/= 37 weeks gestation
- Singleton pregnancies
- Admission for induction of labor or spontaneous labor
Exclusion
- Multiple gestations
- Multiparous patients
- Patients with major fetal anomalies
- Not on oxytocin at the time of complete cervical dilation
- Patients with fetal head visible at the perineum on diagnosis of complete cervical dilation
- Maternal medical condition that prohibits prolonged second stage
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2027
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04303702
Start Date
July 1 2022
End Date
September 30 2027
Last Update
January 5 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Barnes Jewish Hospital
St Louis, Missouri, United States, 63110